Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2024 10:30 ET | Source: Persistence Market Research

Anatomic Pathology Market Poised for Remarkable Growth, Anticipating a 8.2% CAGR Leading to US$6.0 Billion Valuation by 2030, Persistence Market Research

New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The global market for anatomic pathology market is projected to grow at a CAGR of 8.2%, increasing from US$3.5 billion in 2023 to US$6.0 billion by 2030....
January 25, 2019 06:00 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

PARSIPPANY, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced the pricing of an underwritten public offering of...
December 27, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Ranked as Top 10 Bioinformatics Solutions Provider

PARSIPPANY, NJ, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that CIO Applications, a publication focused on providing professionals with...
November 26, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Newly Published Data from National Study Supports Interpace Diagnostics’ PancraGEN®

New Article in Peer-Reviewed Journal Highlights Important Role of PancraGEN® Testing PARSIPPANY, NJ, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
November 07, 2018 08:06 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing

The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
October 24, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Participation at the DJCON18

Including Participation in the Panel on the Impact of AI and Bioinformatics in Healthcare PARSIPPANY, NJ, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
September 17, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Supports Research Efforts of Pancreatic and Thyroid Cancer Patient Advocacy Groups

Interpace Employees Participate in Local Events in Support of Lustgarten Foundation for Pancreatic Cancer Research, Thyroid, Head and Neck Cancer Foundation, and Pancreatic Cancer Action Network ...
August 20, 2018 16:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the 10th Annual Next Generation Dx Summit 2018

Discussing Methods for Securing Coverage and Reimbursement for Molecular Diagnostics PARSIPPANY, NJ, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
July 31, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

PARSIPPANY, NJ, July 31, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...